Literature DB >> 24210353

Bee venom phospholipase A2 induces a primary type 2 response that is dependent on the receptor ST2 and confers protective immunity.

Noah W Palm1, Rachel K Rosenstein, Shuang Yu, Dominik D Schenten, Esther Florsheim, Ruslan Medzhitov.   

Abstract

Venoms consist of toxic components that are delivered to their victims via bites or stings. Venoms also represent a major class of allergens in humans. Phospholipase A2 (PLA2) is a conserved component of venoms from multiple species and is the major allergen in bee venom. Here we examined how bee venom PLA2 is sensed by the innate immune system and induces a type 2 immune response in mice. We found that bee venom PLA2 induced a T helper type 2 (Th2) cell-type response and group 2 innate lymphoid cell activation via the enzymatic cleavage of membrane phospholipids and release of interleukin-33. Furthermore, we showed that the IgE response to PLA2 could protect mice from future challenge with a near-lethal dose of PLA2. These data suggest that the innate immune system can detect the activity of a conserved component of venoms and induce a protective immune response against a venom toxin.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24210353      PMCID: PMC3852615          DOI: 10.1016/j.immuni.2013.10.006

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  44 in total

1.  Allergic host defences.

Authors:  Noah W Palm; Rachel K Rosenstein; Ruslan Medzhitov
Journal:  Nature       Date:  2012-04-25       Impact factor: 49.962

Review 2.  Mechanisms of immunotherapy to wasp and bee venom.

Authors:  C Ozdemir; U C Kucuksezer; M Akdis; C A Akdis
Journal:  Clin Exp Allergy       Date:  2011-07-05       Impact factor: 5.018

3.  Interleukin 33 as a mechanically responsive cytokine secreted by living cells.

Authors:  Rahul Kakkar; Hillary Hei; Stephan Dobner; Richard T Lee
Journal:  J Biol Chem       Date:  2012-01-03       Impact factor: 5.157

Review 4.  Approaching the asymptote? Evolution and revolution in immunology.

Authors:  C A Janeway
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1989

Review 5.  Insights into the initiation of type 2 immune responses.

Authors:  Chris J Oliphant; Jillian L Barlow; Andrew N J McKenzie
Journal:  Immunology       Date:  2011-12       Impact factor: 7.397

6.  IL-33-activated dendritic cells are critical for allergic airway inflammation.

Authors:  Anne-Gaëlle Besnard; Dieudonnée Togbe; Noëlline Guillou; François Erard; Valérie Quesniaux; Bernhard Ryffel
Journal:  Eur J Immunol       Date:  2011-05-25       Impact factor: 5.532

Review 7.  The enigmatic processing and secretion of interleukin-33.

Authors:  Weihua Zhao; Zhiqing Hu
Journal:  Cell Mol Immunol       Date:  2010-03-22       Impact factor: 11.530

Review 8.  New paradigms in type 2 immunity.

Authors:  Bali Pulendran; David Artis
Journal:  Science       Date:  2012-07-27       Impact factor: 47.728

Review 9.  IL-33: a Janus cytokine.

Authors:  F Y Liew
Journal:  Ann Rheum Dis       Date:  2012-04       Impact factor: 19.103

10.  Mast cell chymase reduces the toxicity of Gila monster venom, scorpion venom, and vasoactive intestinal polypeptide in mice.

Authors:  Mitsuteru Akahoshi; Chang Ho Song; Adrian M Piliponsky; Martin Metz; Andrew Guzzetta; Magnus Abrink; Susan M Schlenner; Thorsten B Feyerabend; Hans-Reimer Rodewald; Gunnar Pejler; Mindy Tsai; Stephen J Galli
Journal:  J Clin Invest       Date:  2011-09-19       Impact factor: 14.808

View more
  85 in total

Review 1.  The interleukin-1 family: back to the future.

Authors:  Cecilia Garlanda; Charles A Dinarello; Alberto Mantovani
Journal:  Immunity       Date:  2013-12-12       Impact factor: 31.745

2.  Antibodies: taking the sting out.

Authors:  Yvonne Bordon
Journal:  Nat Rev Immunol       Date:  2013-11-08       Impact factor: 53.106

Review 3.  The route to pathologies in chronic inflammatory diseases characterized by T helper type 2 immune cells.

Authors:  K Jovanovic; M Siebeck; R Gropp
Journal:  Clin Exp Immunol       Date:  2014-11       Impact factor: 4.330

Review 4.  Potential effector and immunoregulatory functions of mast cells in mucosal immunity.

Authors:  L L Reber; R Sibilano; K Mukai; S J Galli
Journal:  Mucosal Immunol       Date:  2015-02-11       Impact factor: 7.313

Review 5.  Mast Cells and IgE can Enhance Survival During Innate and Acquired Host Responses to Venoms.

Authors:  Stephen J Galli; Philipp Starkl; Thomas Marichal; Mindy Tsai
Journal:  Trans Am Clin Climatol Assoc       Date:  2017

Review 6.  The Molecular Basis of Toxins' Interactions with Intracellular Signaling via Discrete Portals.

Authors:  Adi Lahiani; Ephraim Yavin; Philip Lazarovici
Journal:  Toxins (Basel)       Date:  2017-03-16       Impact factor: 4.546

Review 7.  Regulatory constraints in the generation and differentiation of IgE-expressing B cells.

Authors:  Zhiyong Yang; Marcus J Robinson; Christopher D C Allen
Journal:  Curr Opin Immunol       Date:  2014-03-12       Impact factor: 7.486

8.  IL-3 synergises with basophil-derived IL-4 and IL-13 to promote the alternative activation of human monocytes.

Authors:  Francesco Borriello; Michele Longo; Rosa Spinelli; Antonio Pecoraro; Francescopaolo Granata; Rosaria Ilaria Staiano; Stefania Loffredo; Giuseppe Spadaro; Francesco Beguinot; John Schroeder; Gianni Marone
Journal:  Eur J Immunol       Date:  2015-04-28       Impact factor: 5.532

9.  IgE/FcεRI-Mediated Antigen Cross-Presentation by Dendritic Cells Enhances Anti-Tumor Immune Responses.

Authors:  Barbara Platzer; Kutlu G Elpek; Viviana Cremasco; Kristi Baker; Madeleine M Stout; Cornelia Schultz; Eleonora Dehlink; Kai-Ting C Shade; Robert M Anthony; Richard S Blumberg; Shannon J Turley; Edda Fiebiger
Journal:  Cell Rep       Date:  2015-03-05       Impact factor: 9.423

10.  Identification of Epithelial Phospholipase A2 Receptor 1 as a Potential Target in Asthma.

Authors:  James D Nolin; H Luke Ogden; Ying Lai; William A Altemeier; Charles W Frevert; James G Bollinger; Gajendra S Naika; Anthony Kicic; Stephen M Stick; Gerard Lambeau; William R Henderson; Michael H Gelb; Teal S Hallstrand
Journal:  Am J Respir Cell Mol Biol       Date:  2016-12       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.